Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy. Pablo Paez (Co-Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,950,000. 2/1/2025-1/1/2030.
  • Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease. Fraser Sim (Co-Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $2,930,725. 7/1/2023-6/1/2028.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling. Roh-Yu Shen (Principal Investigator). NIAAA. 9/1/2022-8/1/2027.
  • Role of microglia in prenatal ethanol exposure-induced impairment of endocannabinoid signaling. Samir Haj-Dahmane (Co-Investigator). NIH. $1,813,263. 9/1/2022-6/1/2027.
  • The role of the nociceptor endocytosis in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders & Stroke. $1,907,471. 6/1/2022-5/1/2027.
  • Accelerating remyelination using lanthionine ketimine derivatives. Pablo Paez (Principal Investigator). Department of Veterans Affairs. $85,000. 10/1/2022-9/1/2026.
  • Molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. Pablo Paez (Co-Investigator). US Army Medical Research Acquisition Activity. $620,000. 7/1/2023-6/1/2026.
  • Molecular mechanisms and therapeutic potential of heparan sulfate proteoglycans in remyelination. Fraser Sim (Principal Investigator). DoD CDMRP. $998,436. 7/1/2023-6/1/2026.
  • Research training on alcohol etiology and treatment. Caroline Bass (Contributor). NIH, NIAAA. $575,310. 2/16/2022-4/1/2026.
  • Role of inhibitory GABA Projections from the Ventral Tegmental Area in Motivation Learning. Caroline Bass (Principal Investigator). Whitehall Foundation. $225,000. 1/1/2018-12/1/2025.
  • Clinical and Translational Science Award-linked KL2 Mentored Career Development Award. Margarita Dubocovich (Principal Investigator). NIH/NCATS. $2,706,260. 8/1/2015-12/1/2025.
  • An innovative instrument cluster for the integrative behavioral analysis of mouse mutants with perturbed neuronal connectivity. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $175,000. 6/1/2021-11/1/2025.
  • Overcoming human-specific obstacles to successful remyelination in multiple sclerosis. Fraser Sim (Principal Investigator). Department of Defense (CDMRP). 9/1/2021-10/1/2025.
  • OSHA Outreach Center Cooperative Agreement. Paul Kostyniak (Principal Investigator). OSHA. 10/1/2010-9/1/2025.
  • Prenatal Tobacco and Cannabis Exposure: A Translational Study. Panayotis Thanos (Principal Investigator). NIH. 2/1/2022-8/1/2025.
  • Superfund Health & Safety Training Cooperative Agreement-HWWT & HDPT. Paul Kostyniak (Principal Investigator). NIEHS. $109,312. 8/1/2010-7/1/2025.
  • Development of LPA5 Antagonists as Analgesics. Jun-Xu Li (Co-Principal Investigator). NINDS/NIH. $407,125. 7/1/2023-7/1/2025.
  • University at Buffalo, SUNY Occupational Safety & Health Project. Paul Kostyniak (Co-Investigator). NIOSH. $123,837. 7/1/2010-6/1/2025.
  • Accelerating remyelination with lanthionine ketimine – the role of LKE on oligodendrocyte development and remyelination. Pablo Paez (Principal Investigator). National Multiple Sclerosis Society. $85,000. 5/1/2022-4/1/2025.